Astrocyte cell therapy(Kadimastem)

N/A

Report date: 2025/06/22 20:00:04

Base Information

Drug NameAstrocyte cell therapy(Kadimastem)

Drug Alias NameAstroRx

ClassificationCell and gene therapy > Cell therapy > Source of cells > Embryonic stem cell-derivedCell and gene therapy > Cell therapy > Somatic cell > Astrocyte therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsAmyotrophic Lateral Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesKadimastem

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesKadimastem

Active IndicationsN/A

Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A